| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/22/2011 | CN102100707A Cordyceps sinensis health-care liquor |
| 06/22/2011 | CN102100696A Bone joint maintenance composite containing dimethyl sulfone |
| 06/22/2011 | CN102100679A Carprofen matrix tablets |
| 06/22/2011 | CN102100672A Vascular endothelial growth factor chitosan microsphere and application thereof |
| 06/22/2011 | CN101797291B Traditional Chinese medicine for treating osteoproliferation |
| 06/22/2011 | CN101671315B New crystal form of febuxostat and preparation method thereof |
| 06/22/2011 | CN101670058B Traditional Chinese medicine composition for treating gout |
| 06/22/2011 | CN101664493B Preparation for treating fractures of bones and join of fracture |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101569682B Medical composition for treating rheumatoid arthritis and preparation method |
| 06/22/2011 | CN101513484B A medicament composition for preventing and treating osteoporosis and the preparation thereof |
| 06/22/2011 | CN101502598B Medicament for treating protrusion of lumber vertebral disc and method for preparing the same |
| 06/22/2011 | CN101342342B Medicament for treating dorsal disc prolapse |
| 06/22/2011 | CN101322786B External-use medicament for treating bone fracture and traumatic injury |
| 06/22/2011 | CN101239182B Calcium phosphate delivery vehicles for osteoinductive proteins |
| 06/22/2011 | CN101167787B Albizzia plant extraction composition for inhibiting angiogenesis and preparation and application thereof |
| 06/22/2011 | CN101020047B Health food containing calcium reinforcing agent |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964734 Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
| 06/21/2011 | US7964581 Use of difructose anhydride-containing composition |
| 06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2527155C Cationic porphyrin derivatives and uses thereof |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2476929C Tissue repair matrix |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/16/2011 | WO2011071453A1 Glycosaminoglycan mixtures |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011070415A1 Novel therapeutic methods for treating inflammation and immune system disorders |
| 06/16/2011 | WO2011070407A1 N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation |
| 06/16/2011 | WO2011070305A1 Pharmaceutical composition for the treatment of orthopedic pathologies |
| 06/16/2011 | WO2011070172A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/16/2011 | WO2011069214A1 Methods and compositions for bone and cartilage repair |
| 06/16/2011 | WO2011014825A3 Antiangiogenic small molecules and methods of use |
| 06/16/2011 | WO2011009039A3 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 06/16/2011 | US20110144764 Bone graft material |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144120 Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof |
| 06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144116 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144095 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/16/2011 | US20110144083 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/16/2011 | US20110144059 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110143994 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142960 Nutritional supplement for osteoarthritis |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142940 Analgesic Apatitic Calcium-Phosphate Cement |
| 06/16/2011 | US20110142930 Pharmaceutical Compositions of Atorvastatin |
| 06/16/2011 | US20110142928 Process for the production of calcium compositions in a continuous fluid bed |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142902 Hypoxia Inducing Factor (HIF) Stabilising Glasses |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142880 Lentivirus-based immunogenic vectors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142836 B-cell depleting agents for the treatment of chronic fatigue syndrome |
| 06/16/2011 | US20110142831 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/16/2011 | US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 06/16/2011 | US20110142810 Cell preparation for bone tissue regeneration |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142793 Composition for treating articular cartilage defect, and method of manufacture thereof |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2783691A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/16/2011 | CA2783405A1 N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2332991A2 Humanized anti-cd4 antibody with immunosuppressive properties |
| 06/15/2011 | EP2332987A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/15/2011 | EP2332953A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 06/15/2011 | EP2332932A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4 fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |